Prime Minister Boris Johnson visits the UK Corona 19 Vaccination Center▶ Click here to enlarge
In the UK, the number of people who completed the first dose of the novel coronavirus infection (Corona 19) vaccine exceeded 10 million.
The UK’s Ministry of Health said on the 3rd (local time) that 1211,471 people received the first vaccine and 49,8,962 people received the second vaccine.
The UK government is running towards a goal of completing vaccinations to the 15 million people most vulnerable to Corona 19 by mid-February.
Prime Minister Boris Johnson explained at a press conference held that day that 90% of people aged 75 and over in England and all living in elderly care facilities were vaccinated.
Prime Minister Johnson expressed his appreciation that “an important milestone” was reached with the help of everyone, from the scientist who developed the vaccine to the driver who delivered the vaccine.
However, Prime Minister Johnson said the COVID-19 infection rate in the UK is still “surprisingly high,” and that the National Health Service (NHS) is also under “extremely pressure”.
In the UK, 19,202 people were newly diagnosed with Corona 19 on that day, and 1,322 people were reported to have died of Corona 19.
The number of cumulative confirmed cases is 38,71,825, the fifth largest in the world, and the number of cumulative deaths is 109,000, the fifth in the world.
The British responded by overlapping the spread of the mutant virus’B117′, which was first identified in the country in September of last year, followed by the spread of the mutant’E484K’ from South Africa.
Mutant viruses do not cause severe or increase fatality, but have a stronger transmission power than conventional viruses.
The Ministry of Health said it would break the link of the spread of the mutant virus originating in South Africa.
Multinational pharmaceutical company AstraZeneca and Oxford University in the UK have announced that a vaccine to prevent the mutant virus could be released this fall, the BBC said.
Andrew Pollard, a professor at Oxford University who led the clinical trials of the AstraZeneca vaccine, explained that it does not take long because the existing vaccine needs to be changed slightly.
[연합뉴스]
Copyrights ⓒ Yonhap News. Unauthorized reproduction and redistribution prohibited